VStore: Feasibility and acceptability of a novel virtual reality functional cognition taskFRONTIERS IN VIRTUAL REALITYIF3.62022-11-022OA
Alpha3/alpha2 power ratios relate to performance on a virtual reality shopping task in ageing adultsFRONTIERS IN AGING NEUROSCIENCEIF4.52022-09-231OAAI
Vortioxetine as adjunctive therapy in the treatment of schizophreniaTHERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGYIF42022-07-053OAAI
A Novel Virtual Reality Assessment of Functional Cognition: Validation StudyJOURNAL OF MEDICAL INTERNET RESEARCHIF62022-01-2616OAAI
In the eye of the beholder? Oxytocin effects on eye movements in schizophrenia在观者的眼中?催产素对精神分裂症患者眼球运动的影响SCHIZOPHRENIA RESEARCHIF3.52020-02-013OAAI
NEUROANATOMY OF EMOTIONAL PROCESSING AND IMPACT ON CLINICAL OUTCOMES IN SUBJECTS AT HIGH RISK OF PSYCHOSISSCHIZOPHRENIA BULLETINIF4.82019-04-090OAAI
Can we assess cognition and functional capacity simultaneously? Validation of a virtual reality shopping taskEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI
OXYTOCIN ENHANCES VISUAL ATTENTION TO FACIAL STIMULI IN PATIENTS WITH SCHIZOPHRENIA: EVIDENCE FROM AN EYE-TRACKING STUDYSCHIZOPHRENIA BULLETINIF4.82018-04-010OAAI
Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey (vol 7, 15201, 2017)SCIENTIFIC REPORTSIF3.92018-03-013OAAI
Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online surveySCIENTIFIC REPORTSIF3.92017-11-0957OAAI
When the drugs don't work: treatment-resistant schizophrenia, serotonin and serendipityTHERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGYIF42017-11-0221OAAI